Women who regularly consume cannabis experience more intense cravings for the drug than their male counterparts, a study has found.
A new study of the first 400 patients to be prescribed CBD oil in New Zealand suggests that the cannabinoid may be beneficial for treating patients suffering with symptoms of non-cancer pain and mental health conditions.
Supplied by the Latin American company Khiron Life Sciences, the cannabis products will first be issued to UK doctors before being prescribed to the 20,000 patients expected to be involved in the trial.
Although no such breathalyzer has yet been made, the researchers claim their test is inexpensive and effective enough to hold promise for future practical devices.
The $9 million donation will help fund research at Harvard Medical School into how full-spectrum cannabis products differ to those made from a single extracted compound.
Professor Mike Barnes looks to the future of the UK's medical cannabis and CBD sectors.
Popular culture has created an enduring trope of the ‘forgetful stoner’ character, one who is mellowed out to the point of confusion and forgetfulness. But are these tropes actually supported by science?
The findings reveal a new interplay between the two drugs that has never previously been observed, say the scientists.